Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-CONVINCED: Beta-Blocker Continuation Versus Interruption in Heart Failure
NCT00162565Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2004
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of carvedilol in heart failure (HF) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Clinical improvement evaluated by standardized questionnaire at 3 days. Started Nov 2004; status: completed.
02
Drugs
carvedilol
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00162565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162565.